• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病(T2DM)合并代谢功能障碍相关脂肪性肝病(MASLD)患者餐后血糖和胰岛素的时间趋势及影响因素分析:一项基于倾向评分匹配(PSM)的回顾性研究

Analysis of postprandial time trends and influencing factors of blood glucose and insulin in type 2 diabetes mellitus (T2DM) with metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective study based on propensity score matching (PSM).

作者信息

Qi Ge-Yao, Wang Fei, Shi Yuan-Bo, Feng Juan, Xu Jin

机构信息

Department of Internal Medicine, No. 32186 Unit Hospital of People's Liberation Army of China (PLA), Baoding, 071000, Hebei, China.

Department of Cardiology, No. 940 Hospital of Logistics Support Force of People's Liberation Army of China (PLA), Lanzhou, 730050, Gansu, China.

出版信息

Acta Diabetol. 2025 Apr 1. doi: 10.1007/s00592-025-02503-5.

DOI:10.1007/s00592-025-02503-5
PMID:40167632
Abstract

BACKGROUND

Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM) are increasingly prevalent metabolic disorders worldwide, with a complex bidirectional relationship between them. Currently, there is a lack of research on the trajectories of blood glucose and insulin concentration over time after eating in patients with MASLD and T2DM.

METHODS

This clinical cohort included diagnosed T2DM patients in a large hospital over the past five years, was divided into an observation group (with MASLD) and a control group (without MASLD). The postprandial time trends of blood glucose and insulin concentration were analysed within two hours after eating. A strategy of backward iterative feature elimination combined with propensity score matching (PSM) was employed to screen for potential associated factors that might influence these trends.

RESULTS

In total, there were 521 in the observation group and 373 in the control group. In terms of blood glucose, the postprandial time-concentration trajectories for both groups shown a significant time main effect (F = 1145.567, P < 0.001), a significant group main effect (F = 15.340, P < 0.001), and a significant timegroup interaction effect (F = 2.873, P = 0.035); After matching all the factors, the timegroup interaction effect of blood glucose was not significant, but the differences from group main effect still existed. In terms of insulin, the postprandial time-concentration trajectories for both groups shown a significant time main effect (F = 309.429, P < 0.001), a significant group main effect (F = 6.319, P < 0.012), and a significant timegroup interaction effect (F = 20.057, P < 0.001), but the trajectories crossed; After matching 4 factors such as Smoking, Essential Hypertension (EH), Body Mass Index (BMI), Triglyceride (TG) and Ca, neither the group main effect nor the timegroup interaction effect on insulin was significant any more.

CONCLUSION

The postprandial trends of blood glucose and insulin concentration over time shown significant differences between T2DM patients with and without MASLD. IL-6 might be associated with the insulin resistance, while EH and Ca might be related to the islet β-cell function. Smoking and TG might participate in both of the above processes. The strategy of backward iterative with PSM had demonstrated a relatively satisfactory effect in feature screening.

摘要

背景

代谢功能障碍相关脂肪性肝病(MASLD)和2型糖尿病(T2DM)是全球范围内日益普遍的代谢紊乱疾病,二者之间存在复杂的双向关系。目前,关于MASLD和T2DM患者进食后血糖和胰岛素浓度随时间变化的轨迹缺乏研究。

方法

本临床队列纳入了过去五年内某大型医院确诊的T2DM患者,分为观察组(患有MASLD)和对照组(未患MASLD)。分析进食后两小时内血糖和胰岛素浓度的餐后时间趋势。采用向后迭代特征消除结合倾向得分匹配(PSM)策略筛选可能影响这些趋势的潜在相关因素。

结果

观察组共521例,对照组共373例。血糖方面,两组的餐后时间-浓度轨迹均显示出显著的时间主效应(F = 1145.567,P < 0.001)、显著的组间主效应(F = 15.340,P < 0.001)和显著的时间组间交互效应(F = 2.873,P = 0.035);匹配所有因素后,血糖的时间组间交互效应不显著,但组间主效应差异仍然存在。胰岛素方面,两组的餐后时间-浓度轨迹均显示出显著的时间主效应(F = 309.429,P < 0.001)、显著的组间主效应(F = 6.319,P < 0.012)和显著的时间组间交互效应(F = 20.057,P < 0.001),但轨迹交叉;匹配吸烟、原发性高血压(EH)、体重指数(BMI)、甘油三酯(TG)和钙等4个因素后,胰岛素的组间主效应和时间组间交互效应均不再显著。

结论

有和没有MASLD的T2DM患者之间,血糖和胰岛素浓度随时间的餐后趋势存在显著差异。白细胞介素-6可能与胰岛素抵抗有关,而EH和钙可能与胰岛β细胞功能有关。吸烟和TG可能参与上述两个过程。PSM向后迭代策略在特征筛选中显示出相对满意的效果。

相似文献

1
Analysis of postprandial time trends and influencing factors of blood glucose and insulin in type 2 diabetes mellitus (T2DM) with metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective study based on propensity score matching (PSM).2型糖尿病(T2DM)合并代谢功能障碍相关脂肪性肝病(MASLD)患者餐后血糖和胰岛素的时间趋势及影响因素分析:一项基于倾向评分匹配(PSM)的回顾性研究
Acta Diabetol. 2025 Apr 1. doi: 10.1007/s00592-025-02503-5.
2
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.代谢功能障碍相关脂肪性肝病/非酒精性脂肪性肝病与2型糖尿病的关联:巴基斯坦一家三级医疗医院的病例对照研究
Cureus. 2023 Oct 17;15(10):e47240. doi: 10.7759/cureus.47240. eCollection 2023 Oct.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.日本代谢相关脂肪性肝病:2019 年冠状病毒病大流行前 10 年的流行趋势及临床背景。
Medicina (Kaunas). 2024 Aug 16;60(8):1330. doi: 10.3390/medicina60081330.
4
The Mediation Effects of Type 2 Diabetes Mellitus and Related Biomarkers on the Association of Metabolic Dysfunction-associated Steatotic Liver Disease and Fibrosis.2型糖尿病及相关生物标志物在代谢功能障碍相关脂肪性肝病与肝纤维化关联中的中介作用
J Gastrointestin Liver Dis. 2025 Mar 27;34(1):47-54. doi: 10.15403/jgld-5901.
5
The predictive value of triglyceride-glucose-high density lipoprotein-body mass index (TGH-BMI) for different degrees of hepatic steatosis and liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD).甘油三酯-葡萄糖-高密度脂蛋白-体重指数(TGH-BMI)对代谢功能障碍相关脂肪性肝病(MASLD)不同程度肝脂肪变性和肝纤维化的预测价值
Clin Nutr ESPEN. 2025 Apr;66:290-301. doi: 10.1016/j.clnesp.2025.01.041. Epub 2025 Jan 24.
6
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study.1型糖尿病患者的代谢功能障碍相关脂肪性肝病、胰岛素敏感性及连续血糖监测指标:一项多中心横断面研究
Diabetes Obes Metab. 2025 Jun;27(6):3201-3211. doi: 10.1111/dom.16333. Epub 2025 Mar 13.
7
Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients.脂肪细胞因子作为2型糖尿病患者代谢功能障碍相关脂肪性肝病(MASLD)发生的预测指标
Cureus. 2024 Mar 6;16(3):e55673. doi: 10.7759/cureus.55673. eCollection 2024 Mar.
8
Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review.2型糖尿病患者代谢功能障碍相关脂肪性肝病的药物治疗选择:一项系统评价
Eur J Clin Invest. 2025 Apr;55(4):e70003. doi: 10.1111/eci.70003. Epub 2025 Feb 12.
9
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.心脏代谢指标与代谢功能障碍相关脂肪性肝病的发病及其向肝纤维化进展之间的关联:一项队列研究
Cardiovasc Diabetol. 2025 Apr 3;24(1):154. doi: 10.1186/s12933-025-02716-6.
10
Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.性别对代谢相关脂肪性肝病患者骨骼肌量的影响:基于倾向评分匹配研究。
J Nutr Health Aging. 2024 Jun;28(6):100270. doi: 10.1016/j.jnha.2024.100270. Epub 2024 Jun 3.

本文引用的文献

1
High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention.2型糖尿病中代谢功能障碍相关脂肪性肝病的高患病率:迫切需要综合筛查和生活方式干预。
World J Hepatol. 2025 Jan 27;17(1):103409. doi: 10.4254/wjh.v17.i1.103409.
2
Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Persons with Obesity and Type 2 Diabetes Mellitus: A Cross-sectional Study.肥胖和2型糖尿病患者中代谢功能障碍相关脂肪性肝病(MASLD)的患病率:一项横断面研究。
Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):129-133. doi: 10.5005/jp-journals-10018-1437. Epub 2024 Dec 27.
3
Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis.
血浆FSTL-1作为晚期肝纤维化患者的一种非侵入性诊断生物标志物。
Hepatology. 2024 Nov 21. doi: 10.1097/HEP.0000000000001167.
4
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals.负荷后1小时血糖与肥胖个体中经活检证实的代谢功能障碍相关脂肪性肝病有关。
Diabetes Metab. 2025 Jan;51(1):101588. doi: 10.1016/j.diabet.2024.101588. Epub 2024 Dec 5.
5
Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action.代谢功能障碍相关脂肪性肝病:全球行动的紧急呼吁。
touchREV Endocrinol. 2024 Apr;20(1):5-9. doi: 10.17925/EE.2023.20.1.1. Epub 2023 Nov 8.
6
Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome.探寻非酒精性脂肪性肝病/非酒精性脂肪性肝炎与心脏代谢综合征之间的联系
Eur Cardiol. 2024 May 9;19:e03. doi: 10.15420/ecr.2023.26. eCollection 2024.
7
Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease.美国非酒精性脂肪性肝病患者中估计葡萄糖处置率与动脉僵硬度和死亡率之间的关系。
Front Endocrinol (Lausanne). 2024 May 8;15:1398265. doi: 10.3389/fendo.2024.1398265. eCollection 2024.
8
Mortality outcomes in diabetic metabolic dysfunction-associated fatty liver disease: non-obese versus obese individuals.糖尿病代谢相关脂肪性肝病患者的死亡率结局:非肥胖与肥胖个体。
Sci Rep. 2024 May 17;14(1):11320. doi: 10.1038/s41598-024-61896-5.
9
MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: A cross-sectional population study.血糖正常、糖尿病前期和 2 型糖尿病患者的 MAFLD 和肾小球高滤过:一项横断面人群研究。
Diabetes Metab Res Rev. 2024 May;40(4):e3810. doi: 10.1002/dmrr.3810.
10
Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity.代际营养对非酒精性脂肪肝病发展的影响:肠道微生物群、表观遗传学和免疫的相互作用。
Nutrients. 2024 May 3;16(9):1388. doi: 10.3390/nu16091388.